Full-Time
Senior Executive-QC
Piramal Pharma
1,001-5,000 employees
Diversified pharmaceutical company with global services
No salary listed
Senior
Dhar, India
In Person
- 3 - 6 years' experience in a cGMP laboratory setting
- Familiar with cGMP and FDA requirements
- Perform testing on in-process samples, RM's, finished drug product, and stability study samples in support of production, packing release and regulatory filings.
Piramal Pharma Limited operates in the pharmaceutical sector with three main divisions: Piramal Pharma Solutions (CDMO), Piramal Critical Care (hospital generics), and the Consumer Products Division (self-care products). PPS provides development and manufacturing solutions across the drug lifecycle, while PCC focuses on inhaled anesthetics and serves over 100 countries. The Consumer Products Division offers popular brands in the Indian market. Piramal Pharma stands out by utilizing its extensive manufacturing capabilities and global distribution network to effectively meet the needs of pharmaceutical companies, hospitals, and consumers.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
India
Founded
2020
Simplify's Take
What believers are saying
- Increased demand for CDMO services as companies outsource drug development.
- Growing market for inhaled anesthetics due to advancements in surgical procedures.
- Rising consumer interest in self-care products, especially in emerging markets.
What critics are saying
- Increased competition in the CDMO sector from companies like Lonza and Catalent.
- Rising cost of raw materials due to geopolitical tensions and trade restrictions.
- Regulatory scrutiny on inhaled anesthetics in key markets like the USA and Europe.
What makes Piramal Pharma unique
- Piramal Pharma operates through three main divisions: PPS, PCC, and CPD.
- PPS offers comprehensive CDMO services across the drug lifecycle globally.
- PCC specializes in complex hospital generics, particularly inhaled anesthetics.
Help us improve and share your feedback! Did you find this helpful?
Company News
Piramal Pharma secures $216 million financing with corporate guarantee.